Latest acute chest syndrome Stories
On Track for Top-Line Data in Q1 2016 SAN DIEGO, April 21, 2015 /PRNewswire/ -- Mast Therapeutics, Inc.
Acute chest syndrome (ACS) is a complication of sickle cell disease that is characterized by sudden pain and difficulty breathing.
ENERCA is a European Network for Rare and Congenital Anaemias funded by the European Commission and coordinated by IDIBAPS - Hospital ClÃnic of Barcelona.
SAN DIEGO, Feb. 14, 2011 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that it has entered into a definitive agreement to acquire SynthRx, Inc.
HAYWARD, Calif., March 24 /PRNewswire/ -- Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety and efficacy data from the first cohort of 30 patients, an independent Data Safety Monitoring Board (DSMB) has recommended that Anthera's Phase II clinical trial, known as the IMPACTS (Investigation of the Modulation of Phospholipase in Acute ChesT Syndrome) Study can continue under...
NEW YORK (Reuters Health) - Ninety percent of adults with sickle cell anemia have abnormal lung function tests, according to a report in the American Journal of Respiratory and Critical Care Medicine.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.